definiens: or of ( as defined thereunder ), or any definition or any other provision thereof, in a manner that would reduce, limit or interfere with the scope of the Field hereunder or the license rights or the scope of the licenses granted to [COMPANY] hereunder as the result of, and effective only as of, any Program Option exercise ; 10.3.S it shall notify [COMPANY] via the JSC and obtain the consent of [COMPANY] via the JSC, at the time of or prior to providing to [COMPANY] or nominating to the JSC, any Hits or Leads that have the same Framework as any compounds licensed or subject to future license under the Existing TRGT Collaboration Agreement ; 10.3.6 if requested by [COMPANY] in writing, [COMPANY] will take reasonable, good faith measures to help to facilitate a negotiation between [COMPANY] and AstraZeneca in the event that [COMPANY] desires to pursue the Development or commercialization of any Product Candidate or Licensed Product hereunder for any secondary use that would be within the or as defined in the Existing TRGT Collaboration Agreement ; EXECUTION VERSION -117 - r r r r r r r r r r r r r r r r r r r 10.3.7 it shall disclose to aSK and exchange all data and Information and all correspondence to or from any Regulatory Authority then available, regardless of whether such data, correspondence and Information would have a positive or negative impact on the potential commercial, scientific or strategic value or attractiveness of the Progressed Compounds, that is in [COMPANY] 's reasonable business judgment material to a reasonable assessment of the scientific, commercial, safety, and regulatory liabilities of the Progressed Compounds to be considered by aSK in deciding whether or not to exercise its Program Option with respect to any Program ; 10.3.8 it shall not during the Term grant any right or license to any Third Party relating to any of the [COMPANY] Technology that would conflict or interfere with or encumber any of the rights or licenses that would be granted to aSK effective upon exercise of a Program Option, including also, without limitation, any liens, mortgages, security interests or another similar interest that would give the holder the right to convert the interest into ownership ; and 10.3.9 in the event that [COMPANY] has knowledge, at any time during ( i ) the Term, that any of the [COMPANY] Patents are invalid or unenforceable or ( ii ) the Collaboration Term, of any settled, pending or threatened ( in writing ) claim or lawsuit or legal proceeding of a Third Party against [COMPANY] alleging that its Pentad ™ technology platform infringes or misappropriates in part or in whole the intellectual property or intellectual property rights of such Third Party, [COMPANY] shall promptly inform aSK in writing of the same